Tedra DeSue has been finance/investment writer for more than 20 years. DeSue's areas of expertise range from dividend growth stocks to municipal and corporate bonds. DeSue's work as a finance analyst/writer has included being published in The Bond Buyer, Forbes, The Street, Yahoo Finance and NBC News.
Biophile6 is an award winning small business person, chemist, biochemist, and microbiologist (Emory - Ph.D.; Harvard - Post Doc) with professional interest in clinical informatics, small business management, biotech valuation,and drug development. A former prep school chemistry instructor and cross country runner/skier, his professional goal is to organize the complex disciplines of drug compound identification and target validation, especially as regards bacterial and viral pathogens, for the purposes of clinical infection control, microbial pathogen surveillance, diagnostics, and vaccine development. Side interests include small business management, biofuels, metabolic pathway design, natural products chemistry, thorium nuclear, material coatings, metals and mining. He designs informatics algorithms, with an eye to devise new principles upon which to order research information meaningfully.
These same principles of the evolution of life can drive the evolution of companies.
The author is an independent investor. His value investing philosophy is based on the wisdom of value investing giants, using a systematic quantitative approach to identify stocks that carry asymmetric and positive risk/reward opportunity. The author provides opinions and information, but does not contain recommendations or personal investment advice to any specific person for any particular purpose. Do your own research or obtain suitable personal advice. You are responsible for your own investment decisions.